Idiopathic pulmonary fibrosis: effects and optimal management of comorbidities von King, Christopher S, Dr, Nathan, Steven D, Prof

Volltext

Pulmonary hypertension in chronic lung disease and hypoxia von Nathan, Steven D, Barbera, Joan A, Gaine, Sean P, Harari, Sergio, Martinez, Fernando J, Olschewski, Horst, Olsson, Karen M, Peacock, Andrew J, Pepke-Zaba, Joanna, Provencher, Steeve, Weissmann, Norbert, Seeger, Werner

Volltext

Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease von Waxman, Aaron, Restrepo-Jaramillo, Ricardo, Thenappan, Thenappan, Ravichandran, Ashwin, Engel, Peter, Bajwa, Abubakr, Allen, Roblee, Feldman, Jeremy, Argula, Rahul, Smith, Peter, Rollins, Kristan, Deng, Chunqin, Peterson, Leigh, Bell, Heidi, Tapson, Victor, Nathan, Steven D

Volltext

High-Flow Nasal Cannula Therapy in COVID-19: Using the ROX Index to Predict Success von Chandel, Abhimanyu, Patolia, Saloni, Brown, A Whitney, Collins, A Claire, Sahjwani, Dhwani, Khangoora, Vikramjit, Cameron, Paula C, Desai, Mehul, Kasarabada, Aditya, Kilcullen, Jack K, Nathan, Steven D, King, Christopher S

Volltext

Long-term Course and Prognosis of Idiopathic Pulmonary Fibrosis in the New Millennium von Nathan, Steven D., MD, FCCP, Shlobin, Oksana A., MD, FCCP, Weir, Nargues, MD, FCCP, Ahmad, Shahzad, MD, Kaldjob, Julienne M., MD, Battle, Edwinia, RN, Sheridan, Michael J., ScD, du Bois, Roland M., MD

Volltext

The Value and Application of the 6-Minute-Walk Test in Idiopathic Pulmonary Fibrosis von Brown, A Whitney, Nathan, Steven D

Volltext

Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials von Noble, Paul W, Albera, Carlo, Bradford, Williamson Z, Costabel, Ulrich, du Bois, Roland M, Fagan, Elizabeth A, Fishman, Robert S, Glaspole, Ian, Glassberg, Marilyn K, Lancaster, Lisa, Lederer, David J, Leff, Jonathan A, Nathan, Steven D, Pereira, Carlos A, Swigris, Jeffrey J, Valeyre, Dominique, King, Jr, Talmadge E

Volltext

Identifying Barriers to Idiopathic Pulmonary Fibrosis Treatment: A Survey of Patient and Physician Views von Maher, Toby M., Swigris, Jeffrey J., Kreuter, Michael, Wijsenbeek, Marlies, Cassidy, Nicola, Ireland, Lucy, Axmann, Judit, Nathan, Steven D.

Volltext

Targeting the Wnt signaling pathway through R-spondin 3 identifies an anti-fibrosis treatment strategy for multiple organs von Zhang, Mingjun, Haughey, Michael, Wang, Nai-Yu, Blease, Kate, Kapoun, Ann M, Couto, Suzana, Belka, Igor, Hoey, Timothy, Groza, Matthew, Hartke, James, Bennett, Brydon, Cain, Jennifer, Gurney, Austin, Benish, Brent, Castiglioni, Paola, Drew, Clifton, Lachowicz, Jean, Carayannopoulos, Leon, Nathan, Steven D, Distler, Jorg, Brenner, David A, Hariharan, Kandasamy, Cho, Ho, Xie, Weilin

Volltext

Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis von Nathan, Steven D, Prof, Albera, Carlo, MD, Bradford, Williamson Z, MD, Costabel, Ulrich, Prof, Glaspole, Ian, MD, Glassberg, Marilyn K, Prof, Kardatzke, David R, PhD, Daigl, Monica, MSc, Kirchgaessler, Klaus-Uwe, MD, Lancaster, Lisa H, MD, Lederer, David J, MD, Pereira, Carlos A, Prof, Swigris, Jeffrey J, MD, Valeyre, Dominique, Prof, Noble, Paul W, MD

Volltext

Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis von Lancaster, Lisa H, de Andrade, Joao A, Zibrak, Joseph D, Padilla, Maria L, Albera, Carlo, Nathan, Steven D, Wijsenbeek, Marlies S, Stauffer, John L, Kirchgaessler, Klaus-Uwe, Costabel, Ulrich

Volltext

The Future of Lung Transplantation von Nathan, Steven D., MD, FCCP

Volltext

Prevalence and Outcomes of Pulmonary Arterial Hypertension in Advanced Idiopathic Pulmonary Fibrosis von Lettieri, Christopher J., Nathan, Steven D., Barnett, Scott D., Ahmad, Shahzad, Shorr, Andrew F.

Volltext

Progress in the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease von Nathan, Steven D

Volltext

Benefits of Intensive Treadmill Exercise Training on Cardiorespiratory Function and Quality of Life in Patients With Pulmonary Hypertension von Chan, Leighton, MD, MPH, Chin, Lisa M.K., PhD, Kennedy, Michelle, MS, Woolstenhulme, Joshua G., DPT, Nathan, Steven D., MD, FCCP, Weinstein, Ali A., PhD, Connors, Gerilynn, BS, Weir, Nargues A., MD, FCCP, Drinkard, Bart, MSPT, Lamberti, James, MD, FCCP, Keyser, Randall E., PhD

Volltext

The 6-min walk test as a primary end-point in interstitial lung disease von Harari, Sergio, Wells, Athol U, Wuyts, Wim A, Nathan, Steven D, Kirchgaessler, Klaus-Uwe, Bengus, Monica, Behr, Jürgen

Volltext

WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension von Savale, Laurent, Huitema, Marloes, Shlobin, Oksana, Kouranos, Vasilis, Nathan, Steven D, Nunes, Hiliaro, Gupta, Rohit, Grutters, Jan C, Culver, Daniel A, Post, Marco C, Ouellette, Daniel, Lower, Elyse E, Al-Hakim, Tamara, Wells, Athol U, Humbert, Marc, Baughman, Robert P

Volltext

Pulmonary Hypertension and Pulmonary Function Testing in Idiopathic Pulmonary Fibrosis von Nathan, Steven D., Shlobin, Oksana A., Ahmad, Shahzad, Urbanek, Susan, Barnett, Scott D.

Volltext

A review of the challenges, learnings and future directions of home handheld spirometry in interstitial lung disease von Maher, Toby M, Schiffman, Courtney, Kreuter, Michael, Moor, Catharina C, Nathan, Steven D, Axmann, Judit, Belloni, Paula, Bengus, Monica, Gilberg, Frank, Kirchgaessler, Klaus-Uwe, Wijsenbeek, Marlies S

Volltext

Contemporary optimized practice in the management of pulmonary sarcoidosis von Aryal, Shambhu, Nathan, Steven D.

Volltext